IBDEI1XP ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32808,1,4,0)
 ;;=4^Z82.49
 ;;^UTILITY(U,$J,358.3,32808,2)
 ;;=^5063369
 ;;^UTILITY(U,$J,358.3,32809,0)
 ;;=Z82.5^^128^1636^2
 ;;^UTILITY(U,$J,358.3,32809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32809,1,3,0)
 ;;=3^Family Hx of Asthma
 ;;^UTILITY(U,$J,358.3,32809,1,4,0)
 ;;=4^Z82.5
 ;;^UTILITY(U,$J,358.3,32809,2)
 ;;=^5063370
 ;;^UTILITY(U,$J,358.3,32810,0)
 ;;=Z82.61^^128^1636^1
 ;;^UTILITY(U,$J,358.3,32810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32810,1,3,0)
 ;;=3^Family Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,32810,1,4,0)
 ;;=4^Z82.61
 ;;^UTILITY(U,$J,358.3,32810,2)
 ;;=^5063371
 ;;^UTILITY(U,$J,358.3,32811,0)
 ;;=Z82.69^^128^1636^36
 ;;^UTILITY(U,$J,358.3,32811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32811,1,3,0)
 ;;=3^Family Hx of Musculoskeletal System Diseases
 ;;^UTILITY(U,$J,358.3,32811,1,4,0)
 ;;=4^Z82.69
 ;;^UTILITY(U,$J,358.3,32811,2)
 ;;=^5063373
 ;;^UTILITY(U,$J,358.3,32812,0)
 ;;=Z83.3^^128^1636^7
 ;;^UTILITY(U,$J,358.3,32812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32812,1,3,0)
 ;;=3^Family Hx of Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,32812,1,4,0)
 ;;=4^Z83.3
 ;;^UTILITY(U,$J,358.3,32812,2)
 ;;=^5063379
 ;;^UTILITY(U,$J,358.3,32813,0)
 ;;=Z82.71^^128^1636^38
 ;;^UTILITY(U,$J,358.3,32813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32813,1,3,0)
 ;;=3^Family Hx of Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,32813,1,4,0)
 ;;=4^Z82.71
 ;;^UTILITY(U,$J,358.3,32813,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,32814,0)
 ;;=Z82.2^^128^1636^6
 ;;^UTILITY(U,$J,358.3,32814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32814,1,3,0)
 ;;=3^Family Hx of Deafness & Hearing Loss
 ;;^UTILITY(U,$J,358.3,32814,1,4,0)
 ;;=4^Z82.2
 ;;^UTILITY(U,$J,358.3,32814,2)
 ;;=^5063366
 ;;^UTILITY(U,$J,358.3,32815,0)
 ;;=Z84.0^^128^1636^40
 ;;^UTILITY(U,$J,358.3,32815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32815,1,3,0)
 ;;=3^Family Hx of Skin & Subcutaneous Tissue Diseases
 ;;^UTILITY(U,$J,358.3,32815,1,4,0)
 ;;=4^Z84.0
 ;;^UTILITY(U,$J,358.3,32815,2)
 ;;=^5063388
 ;;^UTILITY(U,$J,358.3,32816,0)
 ;;=Z82.79^^128^1636^5
 ;;^UTILITY(U,$J,358.3,32816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32816,1,3,0)
 ;;=3^Family Hx of Congenital Malformations
 ;;^UTILITY(U,$J,358.3,32816,1,4,0)
 ;;=4^Z82.79
 ;;^UTILITY(U,$J,358.3,32816,2)
 ;;=^5063374
 ;;^UTILITY(U,$J,358.3,32817,0)
 ;;=Z80.49^^128^1636^24
 ;;^UTILITY(U,$J,358.3,32817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32817,1,3,0)
 ;;=3^Family Hx of Malig Neop Genital Organs
 ;;^UTILITY(U,$J,358.3,32817,1,4,0)
 ;;=4^Z80.49
 ;;^UTILITY(U,$J,358.3,32817,2)
 ;;=^5063351
 ;;^UTILITY(U,$J,358.3,32818,0)
 ;;=Z80.51^^128^1636^25
 ;;^UTILITY(U,$J,358.3,32818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32818,1,3,0)
 ;;=3^Family Hx of Malig Neop Kidney
 ;;^UTILITY(U,$J,358.3,32818,1,4,0)
 ;;=4^Z80.51
 ;;^UTILITY(U,$J,358.3,32818,2)
 ;;=^321159
 ;;^UTILITY(U,$J,358.3,32819,0)
 ;;=Z80.52^^128^1636^21
 ;;^UTILITY(U,$J,358.3,32819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32819,1,3,0)
 ;;=3^Family Hx of Malig Neop Bladder
 ;;^UTILITY(U,$J,358.3,32819,1,4,0)
 ;;=4^Z80.52
 ;;^UTILITY(U,$J,358.3,32819,2)
 ;;=^5063352
 ;;^UTILITY(U,$J,358.3,32820,0)
 ;;=Z80.59^^128^1636^31
 ;;^UTILITY(U,$J,358.3,32820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32820,1,3,0)
 ;;=3^Family Hx of Malig Neop Urinary Tract Organ
 ;;^UTILITY(U,$J,358.3,32820,1,4,0)
 ;;=4^Z80.59
 ;;^UTILITY(U,$J,358.3,32820,2)
 ;;=^5063353
 ;;^UTILITY(U,$J,358.3,32821,0)
 ;;=Z80.7^^128^1636^26
 ;;^UTILITY(U,$J,358.3,32821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32821,1,3,0)
 ;;=3^Family Hx of Malig Neop Lymphoid,Hematopoietic & Related Tissues
